Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
GEMMABio

June 2026

GEMMABio Market Share Analysis for June 2026

GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.
Industry: N/A
Year Founded--
Employees51 - 200
Annual Revenue--
gemmabiotx.com
GEMMABio
GEMMABio (including company regionals)
  • gemmabiotx.com
    gemmabiotx.com
See more website traffic and engagement information

Total visits to GEMMABio's top domains

Understand GEMMABio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in GEMMABio's top domains

Analyze GEMMABio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on GEMMABio's top domains

See how GEMMABio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


GEMMABio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by GEMMABio

These are the website technologies, by industry, used by GEMMABio top domains

Payment & Currencies (3)

Cart Functionality

Cart Functionality

Content Management System (2)

Squarespace

Squarespace

Conversion & Analytics (2)

Statsig

Statsig

eCommerce (2)

More Technologies

6

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from GEMMABio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGemmabiotx launched Duchenne muscular dystrophy program at 2026 American Society of Gene and Cell Therapy (ASGCT) conference on May 14th '26.GEMMABio announces Duchenne Muscular Dystrophy program, shares preclinical data for investigational gene therapy for Duchenne.
NewsGemmabiotx attended event INAME 2025 Spinal Muscular Atrophy Congress on Nov 21st '23.The promising preclinical data from GEMMABio's first clinical-stage program was presented by the company's President and CEO, James M. Wilson, MD, PhD, at the INAME 2025 Spinal Muscular Atrophy Congress which took place on November 21-23, 2025, in São Paulo, Brazil.

See all GEMMABio signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.